4//SEC Filing
Spellman David A 4
Accession 0001562180-23-002038
CIK 0001517022other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:05 PM ET
Size
4.9 KB
Accession
0001562180-23-002038
Insider Transaction Report
Form 4
Spellman David A
SVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2023-02-27$0.81/sh−7,539$6,131→ 517,260 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001733204
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:05 PM ET
- Size
- 4.9 KB